Background HTML Whitewashed

Showing posts with label Immunotherapy. Show all posts
Showing posts with label Immunotherapy. Show all posts

Saturday, January 14, 2023

Clinical Trial Gives Hope

 Reesa Levy shares her story at PanCan and spreads Hope!


“I can’t believe it. Reesa, of all people…”

When Reesa Levy’s friends and family found out she had pancreatic cancer three years ago, this was a common response.

She was a vegetarian, worked out several times a week and never had health issues.

Perhaps those were some of the reasons her doctor had suspected something far less threatening when she came in with excruciating abdominal pain.

A CT scan revealed appendicitis, so her doctor scheduled an appendectomy.

But when the pain didn’t go away after surgery, it was clear that something more was wrong.

“I was also tired and losing a lot of weight – 18 pounds – quickly,” Reesa said.

A subsequent scan revealed a mass on her pancreas, and though Reesa and her doctor were hopeful it was benign, a follow-up biopsy showed otherwise.

Her doctor delivered the news. “There are cancer cells on your pancreas,” he said matter-of-factly as she sat, stunned.

In control of her healthcare

Reesa is a take-charge person.


A retired New York City school principal, she was accustomed to managing the challenges that come with overseeing 2,500 high school students. But pancreatic cancer is a challenge no one can prepare for. Reesa was overwhelmed. Numb. Devastated.

Together, with her daughter and son now with her in Florida, they came up with a game plan: “You have to be in charge of your own healthcare.”

Just five days after the January 2018 diagnosis, Reesa flew  to St. Louis, where her daughter Ashley lives, for an appointment with a surgeon at Siteman Cancer Center at Barnes-Jewish Hospital, the teaching hospital for the Washington University School of Medicine.

Ashley had stepped in to handle the details of her mother’s treatment and care while Reesa tried to focus on the big picture – staying positive for a good outcome. She steered clear of the internet while Ashley dove in, learning about the latest pancreatic cancer research, clinical trials, specialists and more.



It was Ashley who had found the surgeon, William Hawkins M.D., a pancreatic cancer specialist who would perform her distal pancreatectomy. She chose Dr. Hawkins because he had performed hundreds of these types of surgeries.

“I’m very grateful for my family’s help during this stressful time – making calls, asking questions, interviewing doctors, and getting appointments and second opinions,” Reesa said.

One week after her diagnosis, Reesa had laparoscopic surgery to remove the tail of her pancreas, part of her stomach and colon, and her spleen.

A clinical trial option

The Pancreatic Cancer Action Network (PanCAN) strongly recommends clinical trials at diagnosis and during every treatment decision. PanCAN Patient Services can give you information about clinical trials and search for trials that meet your needs.

Even before surgery, Reesa’s doctor had spoken to her about all her treatment options, including clinical trials. “There’s something new you may want to consider,” he told her.

After six months of standard chemotherapy, Reesa was cancer-free and eligible to begin the immunotherapy clinical trial Dr. Hawkins had mentioned, which was studying a vaccine to treat the cancer.

Each person in the study had a different vaccine made from a sample of their own tumor tissue, to encourage the body to fight cancer with their own immune system.

Once a month for six months, the immunotherapy vaccine was administered, along with a small electrical current, into her arm. Reesa did well on the trial and still shows no signs of cancer today.

“My goddaughter, who is a doctor, suggested early on that I join any study I was offered,” Reesa said. “I’m a huge proponent of clinical trials and think all patients should consider one, both for themselves and for future patients. You’ll also get regular CT scans, bloodwork and constant monitoring by your healthcare team.

“I also encourage going to a teaching hospital, if you can. They’re usually on the cutting edge of research and treatment. The team that treated me was full of experts in pancreatic cancer.”

Contact PanCAN for help finding a specialist in your area.

“It really humbled me, all the people surrounding me to make me better.”

 Giving others the chance she had

Today Reesa is enjoying a volunteer role as Advocacy Chair for the Broward-Palm Beach (Fla.) Affiliate of PanCAN. She’s seen first-hand that the volunteering she does – encouraging her members of Congress to increase federal research funding for pancreatic cancer – is making a difference for her and other patients.

One specific way it’s hit home: the immunotherapy clinical trial Reesa participated in was funded by the National Cancer Institute.

She also participates in her local PanCAN PurpleStride and has raised more than $8,000 for PanCAN, money that will go toward funding patient programs and services like our Patient Services, our Clinical Trial Finder and our Precision PromiseSM clinical trial platform, as well as scientific research grants and government advocacy work.

The reason for her continued involvement with PanCAN is simple.

“I have to do something to help other people have the same chance that I’ve had,” she said.

Wednesday, September 4, 2019

Revolutionizing Cancer Treatment

He was 10 years old when his mother died from Lymphoma.

Last year he was awarded the Nobel Prize for his ground-breaking work on Immunotherapy as a revolutionary new cancer treatment.

Meet Dr. James Allison.



In a nutshell, immunotherapy is all about freeing the immune system to attack tumors. Specifically, Dr. Allison's work takes the brakes off  the T cells, the "soldier's" of the immune system, allowing them to battle invading cancer cells.

His work has led to the development of a class of drugs known as checkpoint inhibitors.  One drug, called Yervoy, has been approved for late-stage melanoma, and has already yielded unprecedented results.  20% of the patients with advanced melanoma cancer now live for at least 3 years, and many live 10 years or longer. That's beyond exciting news!

Dr. Allison feels that immunotherapy is quickly becoming the "fourth pillar" of cancer therapy, joining the traditional treatments of surgery, radiation and chemotherapy.



And while immunotherapy doesn't replace traditional treatment, it can be used in conjunction with chemotherapy and radiation to offer patients a strong offense in the cancer fight.  And one other exciting aspect of immunotherapy is that it appears to continue working even after treatment has stopped.

Research continues to investigate treating other cancers with this new type of immunotherapy.  These clinical trials offer a hope that is desperately needed on the cancer battlefield.

We are holding our breath to hear that pancreatic cancer has been spotlighted... so far, the research has focused on lung, kidney, bladder, gastric, liver, cervical, colorectal, head and neck, and lymphoma cancers.

The excitement is not lost on Dr. Allison:

"It's a great, emotional privilege to meet cancer patients who've been successfully treated with immune checkpoint blockade.  They are living proof of the power of basic science, of following our urge to learn and to understand how things work."

That 10 year old boy channeled his loss into extraordinary gains in the fight against cancer.

The president of MD Anderson, Dr. Peter Pisters, believes that "Jim Allison's research has led to life-saving treatments for people who otherwise would have little hope."

And that's some exciting news for the cancer fight!


Friday, May 3, 2019

Another Option for the Fight

In March of 2017, Karen Kiernan received the news that we all fear...

Her recent digestive issues, her weight loss and nagging back pain, they were the result of an aggressive pancreatic cancer growth.  A stage IV pancreatic cancer diagnosis.

The diagnosis left her overwhelmed and in shock.  We've been there too.  The first days and weeks of a cancer diagnosis can leave you reeling.

Thank goodness for family and friends!  Karen's sister dug in deep and began the research that has ultimately given Karen great hope.

Her sister encouraged her to have her tumor profiled with PanCan's Know your Tumor program.

The tissue sample showed a rare mutation that is known to respond to a relatively new immunotherapy drug called Keytruda.  Within weeks of starting the Keytruda regimen, her cancer stabilized, giving her the added relief of her back pain easing and a noticeable improvement in her overall well-being.

You may have seen the ads on TV for Keytruda.  It has been largely targeted towards those with Non-Small Cell Lung Cancer, but has been approved for any solid tumor that displays certain molecular characteristics.

According to the manufacturer, Keytruda works by blocking the PD-1 pathway to help prevent cancer cells from hiding.  Keytruda helps the immune system do what it was meant to do: detect and fight cancer cells.  

Keytruda is an immunotherapy treatment that is showing good results for those with certain mutations in the pancreatic cancer tumor.  This molecular mutation is somewhat rare in pancreatic cancer tumors, appearing in only 1-3% of these tumors.  And while this may be a slim number of pancreatic cancer patients, if it can help even a handful it is so worth shouting the news from the rooftops!

Karen shares her story over at the PanCan website as a way to shed light on the potential for new pancreatic cancer treatments and the hope they give.

Learn more about the Know your Tumor program and see if one of these newer treatments might be a good option for you!

As always, check with your medical team.  We celebrate the Hope of potential new treatments, but we never lose sight of the heavy responsibility of sharing truth and not unrealistic pipe dreams.

We battle together, fighting until a Cure is found...
In Grace, Always,
Jane




Friday, October 24, 2014

Immunotherapy, Vaccines...and Clinical Trials

Digging in Deep today, so hold on to your ride... we've got a lot to cover.

I think we can all agree that Pancreatic Cancer is one of the most deadly of all cancers.  We've talked pancreatic cancer statistics before... and they are just plan terrifying. 

It's imperative to find new therapies and treatments that will extend and save the lives of those impacted by this disease. 

It is the heartbeat of this daughter.  I would give anything to have my mom back, whole and healed.



The missing is a pain I live with everyday.  And I lay that hurt firmly at the door of pancreatic cancer. 

There is a cure.  We must find it.  My prayer is that those reading this blog will be on the healing end of that journey...  whether it's a traditional treatment or an alternative therapy, or a combination of both... healed and whole is the goal...

Which brings us to the finding of that cure.  I wish it was as easy as pulling a rabbit out of the hat.  But, unfortunately, the wheels of medicine and science turn much slower than that.

Enter the Clinical Trial.   It is the way new treatments run the gauntlet.  Either they make it thru or they fizzle in the trying. 

And this is the infuriating part.  The ones that show promise, a.k.a. the treatments that seem to be working in the fight, well, we still have to wait for the FDA to approve their use.  It's a waiting that sometimes takes months, if not years for promising therapies to get approved...

Pancreatic Cancer Patients do not have months to wait for promising treatments. Period.

They are needed now.

And so, it is a difficult thing for me to include these next treatments here.  For you to read about.  When they are not widely available for treatment.

Seems more than cruel.  But it is also the spring of Hope that Help is on the Way...

There are two treatments to discuss today.  They waffle between traditional and alternative.  In one sense they are traditional, dealing with medical and biological science.  On the other hand they don't fall easily into either the chemotherapy or radiation camp of conventional cancer treatment.  So, we'll discuss them based on merit alone, irregardless of what camp they fall into...

Back to the two treatments...two treatments that seem to go hand in hand.  Treatments that are right now in promising clinical trials, one that has even made the fast-track breakthrough designation thru FDA...

Stick with me when the definitions and medical jargon make your eyes glaze over.  There's a point where it all comes together... Promise.

So the two treatments... Immunotherapy and Vaccines

Immunotherapy is the treatment to stimulate or restore the ability of the immune (or defense) system in our bodies to fight disease.

Vaccines are products that stimulate a person's immune system to produce immunity to a specific disease and protect that person from said disease.

See where they're going here?  Immunity against Pancreatic Cancer.

To be immune to pancreatic cancer means that you can be exposed to it, in other words, your wayward pancreas can go all postal and try to grow cancer, but still you will not get pancreatic cancer.

Got your attention?  Yes?!  Sounds unbelievably good.  (Skepticism kicking in, but hang with me...)

One new treatment uses a "powerful new technology in genetic engineering that turns our own immune cells into 'specially trained assassins' capable of finding, attaching, and eliminating pancreatic cancer tumors."  Source:  Cancer Research Institute 

And then it goes and gets so very complicated in terms of medical lingo... So, my simple version is this...

The doctors have found a way to turn our T-cells on and give them orders to find and kill the pancreatic cancer cells.  I know, I know... sounds like a Sci-Fi thriller.  But it has shown promising results with leukemia patients and now the immunotherapy clinical trial is working on pancreatic cancer.

(p.s... T-Cells are types of white blood cells that are at the core of our immune responses. They're the good guys!)

Another new treatment in clinical trials right now is called The CRS-207 and GVAX trial.

Right?  It's all alphabet soup, but what does it mean... that's what I really want to know!

So, again, simple, simple...

The alphabet code names stand for two difference anti-cancer vaccines, CRS-207 and GVAX.  When given in sequence the combination essentially trains the body to recognize and attack pancreatic tumors.  The GVAX vaccine, developed by Dr. Elizabeth Jaffee, was designed to "reprogram" tumors to include immune system T-cells (the good guys) which are then able to fight the cancer from within.

Working in the same vein, researchers from the John Hopkins University School of Medicine have found that a combination of the GVAX vaccine and a low-dose chemotherapy may have made the pancreatic cancer more susceptible to the effects of immunotherapy.  This is a rather important finding because pancreatic cancer tumors are considered by many in the medical field to be nonimmunogenic...in other words not very receptive to the immunotherapy idea.  For a more in-depth study of this therapy, you can read the article in its entirety here.

Are you eyes glazing over yet?

Well, to make a long story even longer, the CRS-207/GVAX trial has actually received a breaththrough therapy designation from the FDA for its potential as a treatment for patients with advanced pancreatic cancer.  The FDA made this designation based on the very promising results from a phase II clinical study.  In this study patients with metastatic pancreatic cancer lived an average 46% longer than those not given the trial vaccine/immunotherapy...

Does that mean we've found the cure??? Stop the presses and all that?!

I'm not jumping on that bandwagon yet... This treatment is still in its infancy.   But, oh, the possibilities.

Can you feel the Hope?

And yet, much of what I have shared today can only be found in the Clinical Trials.

So...the question begs... When are Clinical Trials Recommended?  I mean, let's say you have been given the horrifying diagnosis of pancreatic cancer... when do you stay the line with traditional treatments?  When do you take the leap and commit to a clinical trial?

The Cancer Research  Institute addresses this very issue for pancreatic cancer patients:

"Because of the poor prognosis and the lack of effective treatment options, for pancreatic cancer a clinical trial is nearly always preferred over existing treatment options for everything except localized tumors that can be removed surgically.  Specifically, pancreatic cancer patients are encouraged to participate in clinical trials:

* As adjuvant treatment after surgery for local disease
* When pancreatic cancer returns after surgery
* For unresectable disease (inoperable), when patient is in good condition
* After first-line treatment for locally advanced cancer of metastatic, if the patient has good performance status"

The Cancer Research Institute offers a Clinical Trial Finder that helps patients find current clinical trials of immunotherapies for pancreatic cancer that are currently enrolling patients.
Praying that you are not overwhelmed by so much information on the newer immunotherapies and cancer vaccines.  It is a lot to swallow isn't it?!

This is where information overload can de-rail a person fast.

My enouragement to you right now?  Take a Grace Break or two... decisions are made best after Peace has descended to calm your heart and spirit...

Lifting you up in Grace this day, Always,
                                                         Jane